ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Former PHS Official Jeffrey Koplan To Head CDC; Caligiuri Wins Freireich Award

July 17, 1998

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

AACR Elion Award Deadline Is Jan. 10

September 16, 1994

Grand Jury Clears Eppley, Shubik

October 24, 1980